Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis.

Qi ZhangLe LiHongze ChenGuangquan ZhangSiqiang ZhuRui KongHua ChenGang WangBei Sun

Published in: Journal of clinical laboratory analysis (2019)

Soluble urokinase plasminogen activator receptor is of good predictive value for SAP risk and may serve as a potential biomarker for disease severity, inflammation, and inhospital mortality in SAP patients.

Keyphrases

oxidative stress
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
cardiovascular events
risk factors
binding protein
early onset
coronary artery disease
patient reported outcomes